John T. Randolph

2.5k total citations
39 papers, 1.7k citations indexed

About

John T. Randolph is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, John T. Randolph has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Infectious Diseases and 14 papers in Organic Chemistry. Recurrent topics in John T. Randolph's work include HIV/AIDS drug development and treatment (18 papers), Hepatitis C virus research (13 papers) and Carbohydrate Chemistry and Synthesis (9 papers). John T. Randolph is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), Hepatitis C virus research (13 papers) and Carbohydrate Chemistry and Synthesis (9 papers). John T. Randolph collaborates with scholars based in United States, United Kingdom and Sweden. John T. Randolph's co-authors include Samuel J. Danishefsky, Kim F. McClure, Roger B. Ruggeri, David A. DeGoey, Larry L. Klein, Mark T. Bilodeau, Shuanghua Hu, Tae Kyo Park, Peggy Huang and Edward Tam and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

John T. Randolph

39 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John T. Randolph 1.1k 817 292 255 248 39 1.7k
Stefania Di Marco 1.8k 1.6× 309 0.4× 275 0.9× 330 1.3× 249 1.0× 32 2.6k
Radhakrishnan P. Iyer 2.0k 1.7× 566 0.7× 141 0.5× 291 1.1× 343 1.4× 101 2.7k
Pierre Raboisson 634 0.6× 555 0.7× 636 2.2× 534 2.1× 497 2.0× 60 1.8k
Ted Fox 1.3k 1.1× 122 0.1× 449 1.5× 435 1.7× 198 0.8× 24 2.0k
Pierre Bonneau 677 0.6× 394 0.5× 214 0.7× 279 1.1× 411 1.7× 39 1.6k
Francesco Saverio Di Leva 1.0k 0.9× 365 0.4× 65 0.2× 137 0.5× 306 1.2× 67 1.8k
Seth F. Harris 1.1k 1.0× 184 0.2× 186 0.6× 224 0.9× 238 1.0× 45 1.7k
Ryan P. Murelli 421 0.4× 551 0.7× 142 0.5× 304 1.2× 143 0.6× 59 1.3k
T.C. Appleby 775 0.7× 276 0.3× 305 1.0× 272 1.1× 361 1.5× 29 1.5k
Nathalie Goudreau 687 0.6× 294 0.4× 371 1.3× 206 0.8× 492 2.0× 42 1.5k

Countries citing papers authored by John T. Randolph

Since Specialization
Citations

This map shows the geographic impact of John T. Randolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Randolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Randolph more than expected).

Fields of papers citing papers by John T. Randolph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Randolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Randolph. The network helps show where John T. Randolph may publish in the future.

Co-authorship network of co-authors of John T. Randolph

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Randolph. A scholar is included among the top collaborators of John T. Randolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Randolph. John T. Randolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voight, Eric A., Stephen N. Greszler, J. B. Hartung, et al.. (2021). Desymmetrization of pibrentasvir for efficient prodrug synthesis. Chemical Science. 12(29). 10076–10082. 3 indexed citations
2.
Randolph, John T., Tongmei Li, A. Chris Krueger, et al.. (2020). Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(7). 126986–126986. 3 indexed citations
3.
Randolph, John T., Eric A. Voight, Stephen N. Greszler, et al.. (2020). Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530). Journal of Medicinal Chemistry. 63(19). 11034–11044. 11 indexed citations
4.
Randolph, John T., Charles A. Flentge, Todd W. Rockway, et al.. (2016). Discovery of fluorobenzimidazole HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(22). 5462–5467. 4 indexed citations
5.
Randolph, John T., Peggy Huang, Rolf Wagner, et al.. (2013). High potency improvements to weak aryl uracil HCV polymerase inhibitor leads. Bioorganic & Medicinal Chemistry Letters. 23(15). 4367–4369. 5 indexed citations
6.
Liu, Yaya, Charles A. Flentge, Douglas K. Hutchinson, et al.. (2012). Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(11). 3747–3750. 20 indexed citations
7.
Hu, Jiaxin, Keith T. Gagnon, Jing Liu, et al.. (2011). Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs. Biological Chemistry. 392(4). 315–25. 45 indexed citations
8.
Waring, Jeffrey F., Rita Ciurlionis, Kennan C. Marsh, et al.. (2010). Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia. Archives of Toxicology. 84(4). 263–270. 9 indexed citations
9.
Flentge, Charles A., John T. Randolph, Peggy Huang, et al.. (2009). Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs. Bioorganic & Medicinal Chemistry Letters. 19(18). 5444–5448. 9 indexed citations
10.
Randolph, John T., Xiaolin Zhang, Peggy Huang, et al.. (2008). Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(8). 2745–2750. 24 indexed citations
11.
Konstantinidis, Alex K., Paul L. Richardson, Rakesh Tripathi, et al.. (2007). Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease. Analytical Biochemistry. 368(2). 156–167. 9 indexed citations
12.
Kempf, Dale J., Cheri E. Klein, Hui-Ju Chen, et al.. (2007). Pharmacokinetic Enhancement of the Hepatitis C Virus Protease Inhibitors VX-950 and SCH 503034 by Co-Dosing with Ritonavir. Antiviral chemistry & chemotherapy. 18(3). 163–167. 33 indexed citations
13.
Randolph, John T., Peggy Huang, David A. DeGoey, et al.. (2006). Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry. 14(12). 4035–4046. 10 indexed citations
14.
Kempf, Dale J., Jeffrey F. Waring, David C. Morfitt, et al.. (2006). Practical Preclinical Model for Assessing the Potential for Unconjugated Hyperbilirubinemia Produced by Human Immunodeficiency Virus Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 50(2). 762–764. 6 indexed citations
15.
Yeung, Clinton M., Larry L. Klein, Charles A. Flentge, et al.. (2005). Oximinoarylsulfonamides as potent HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(9). 2275–2278. 27 indexed citations
16.
Huang, Peggy, John T. Randolph, Larry L. Klein, et al.. (2004). Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(15). 4075–4078. 10 indexed citations
17.
Randolph, John T., Daryl R. Sauer, Fortuna Haviv, Angela M. Nilius, & Jonathan Greer. (2004). Elimination of antibacterial activities of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A. Bioorganic & Medicinal Chemistry Letters. 14(6). 1599–1602. 9 indexed citations
18.
Randolph, John T.. (1997). Stability, specificity and fluorescence brightness of multiply-labeled fluorescent DNA probes. Nucleic Acids Research. 25(14). 2923–2929. 138 indexed citations
19.
Danishefsky, Samuel J., Victor Behar, John T. Randolph, & Kenneth O. Lloyd. (1995). Application of the Glycal Assembly Method to the Concise Synthesis of Neoglycoconjugates of Ley and Leb Blood Group Determinants and of H-Type I and H-Type II Oligosaccharides. Journal of the American Chemical Society. 117(21). 5701–5711. 57 indexed citations
20.
Joseph, Cecil K., Samuel D. Wright, W. G. BORNMANN, et al.. (1994). Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. Journal of Biological Chemistry. 269(26). 17606–17610. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Di Marco Breakdown of academic impact, for papers by Radhakrishnan P. Iyer Breakdown of academic impact, for papers by Pierre Raboisson Breakdown of academic impact, for papers by Ted Fox Breakdown of academic impact, for papers by Pierre Bonneau Breakdown of academic impact, for papers by Francesco Saverio Di Leva Breakdown of academic impact, for papers by Seth F. Harris Breakdown of academic impact, for papers by Ryan P. Murelli Breakdown of academic impact, for papers by T.C. Appleby Breakdown of academic impact, for papers by Nathalie Goudreau
Rankless by CCL
2026